Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society…

By Jan Boren, M. Chapman, Ronald M. Krauss, C. Packard, J. Bentzon, C. Binder, M. Daemen, L. Demer, R. Hegele, Stephen J. Nicholls and 20 more. European Heart Journal, 2020

1,302 citations recorded by the source corpus.

Abstract

Subfields: Cancer Research, Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/3ff51a04cbb6dbd4f9301cb36755d45d0bc71096

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Børge G. Nordestgaard
2. Jan Boren
3. Marja-Riitta Taskinen
4. S. Tsimikas
5. M. Laplante
6. David M. Sabatini

In Immunology

1. Bart Staels
2. Alberico L. Catapano

In Surgery

1. Børge G. Nordestgaard
2. Jan Boren
3. M. Chapman
4. Marja-Riitta Taskinen
5. Alberico L. Catapano
6. L. Tokgözoğlu
7. Bart Staels
8. S. Kersten

Citations in the corpus

• Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021, background): “17,25,93,104,206”